Across TCGA pan-cancer cohorts, LINC02504 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02504 data layer.
The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC02504 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02504 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.
READ, KIRP, and UVM are the cancer types where LINC02504 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.